1,190 results on '"Schwarz Kathleen"'
Search Results
102. Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B
103. Dysregulation of upstream and downstream transforming growth factor-β transcripts in livers of children with biliary atresia and fibrogenic gene signatures
104. Recruitment and Retention Strategies in a Clinical Trial for Children With Chronic Hepatitis C Infection
105. Seroprevalence of HCV Infection in Homeless Baltimore Families
106. Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B
107. Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection
108. Percutaneous Transhepatic Cholangioplasty to Treat Multiple Intrahepatic Biliary Strictures After Hepatoportoenterostomy
109. Ascites in Children: A Single-Center Experience of 27 Years
110. More Lessons From the Taiwanese Hepatitis B Virus Vaccine Program
111. Expression of HLA and Autoimmune Pathway Genes in Liver Biopsies of Young Subjects With Autoimmune Hepatitis Type 1
112. Improving the Accuracy of Atomistic Simulations of the Electrochemical Interface
113. Hepatitis
114. Board Games and Regulars’ Tables — Extending User Centred Design in the Mobia Project
115. Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B
116. The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C
117. Erratum: “Interfacial water asymmetry at ideal electrochemical interfaces” [J. Chem. Phys. 156, 014705 (2022)]
118. Compressive Stress and Charge Redistribution during CO Adsorption onto Pt
119. Interfacial water asymmetry at ideal electrochemical interfaces
120. Randomized, Controlled Trial of Entecavir Versus Placebo in Children With Hepatitis B Envelope Antigen–Positive Chronic Hepatitis B
121. Oil in the Machine: Technical Support for a Human-Centred Service System for Public Transport
122. Metabolic Disorders in the Older Child
123. No Hepatitis G virus co-infection in migrants with Hepatitis B or C hosted in Sardinia and Sicily
124. P-6 SOFOSBUVIR CONTAINING REGIMENS ARE SAFE AND EFFECTIVE IN ADOLESCENTS WITH CHRONIC HEPATITIS C INFECTION
125. Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada
126. Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
127. Presentation and Outcomes of Infants With Idiopathic Cholestasis: A Multicenter Prospective Study
128. The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B
129. Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia
130. Epigenetic Regulation of Hepatitis B Virus Infection
131. Long-Term Growth Outcomes in Children Treated for Chronic Hepatitis C
132. Complete Absence of the Extrahepatic Biliary Tree in a Newborn With Pigmented Stools
133. Changes in serum hepatitis B surface and e antigen, interferon‐inducible protein 10, and aminotransferase levels during combination therapy of immune‐tolerant chronic hepatitis B.
134. 422 ORAL VANCOMYCIN THERAPY IS ASSOCIATED WITH IBD CLINICAL REMISSION IN PEDIATRIC PSC-IBD
135. Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver
136. Positive Impact of a Shelter-based Hepatitis B Vaccine Program in Homeless Baltimore Children and Adolescents
137. THE PRESENCE OF A TRUNCATING MUTATION IN ABCB11 ABROGATES THE BENEFICIAL EFFECT OF A RESIDUAL FUNCTION MUTATION ON THE COURSE OF SEVERE BILE SALT EXPORT PUMP DEFICIENCY
138. Sofosbuvir and Ribavirin Therapy for Children 3 to <12 Years Old With Hepatitis C Virus Genotype 2 or 3 Infection
139. Idiopathic Neonatal Hepatitis and Its Differential Diagnoses
140. Sofosbuvir and Ribavirin Therapy for Children 3 to <12 Years Old With Hepatitis C Virus Genotype 2 or 3 Infection
141. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis
142. Unique Pattern of Intrahepatic T-cell Clonality in Biliary Atresia Livers Versus Intestinal Controls: A Pilot Study
143. Quantifying Uncertainties in Solvation Procedures for Modeling Aqueous Phase Reaction Mechanisms
144. CASE REPORT: Malignant Peritoneal Mesothelioma in a Pediatric Patient Mimicking Inflammatory Bowel Disease
145. 193 SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
146. Pediatric issues in new therapies for hepatitis B and C
147. An Exceptional Family with Three Consecutive Generations Affected by Wilson Disease
148. Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation
149. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain
150. List of Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.